Van Berkom & Associates Inc. lowered its stake in Chemed Corporation (NYSE:CHE – Free Report) by 5.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 165,088 shares of the company’s stock after selling 9,781 shares during the period. Chemed makes up approximately 2.1% of Van Berkom & Associates Inc.’s holdings, making the stock its 29th largest holding. Van Berkom & Associates Inc.’s holdings in Chemed were worth $62,360,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Copeland Capital Management LLC increased its position in shares of Chemed by 7.6% in the first quarter. Copeland Capital Management LLC now owns 147,957 shares of the company’s stock valued at $55,889,000 after acquiring an additional 10,406 shares during the period. Bessemer Group Inc. lifted its holdings in Chemed by 26.3% in the first quarter. Bessemer Group Inc. now owns 1,109 shares of the company’s stock worth $419,000 after buying an additional 231 shares during the period. Allspring Global Investments Holdings LLC boosted its position in shares of Chemed by 7.9% during the first quarter. Allspring Global Investments Holdings LLC now owns 107,215 shares of the company’s stock valued at $40,481,000 after purchasing an additional 7,807 shares in the last quarter. D.A. Davidson & CO. bought a new stake in shares of Chemed during the first quarter valued at approximately $254,000. Finally, Illinois Municipal Retirement Fund grew its position in shares of Chemed by 2.9% in the 1st quarter. Illinois Municipal Retirement Fund now owns 12,036 shares of the company’s stock worth $4,546,000 after buying an additional 340 shares during the period. 95.85% of the stock is currently owned by institutional investors.
Insider Buying and Selling
In other Chemed news, Director Andrea R. Lindell sold 1,347 shares of the business’s stock in a transaction that occurred on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total transaction of $602,553.51. Following the sale, the director directly owned 4,578 shares of the company’s stock, valued at $2,047,876.74. The trade was a 22.73% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction that occurred on Friday, May 1st. The shares were sold at an average price of $421.13, for a total value of $842,260.00. Following the completion of the sale, the chief executive officer directly owned 90,219 shares of the company’s stock, valued at $37,993,927.47. The trade was a 2.17% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 3.33% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets
Check Out Our Latest Analysis on Chemed
Chemed Price Performance
Shares of NYSE:CHE opened at $509.89 on Monday. The company has a market capitalization of $6.77 billion, a P/E ratio of 27.79, a P/E/G ratio of 1.88 and a beta of 0.52. The company has a debt-to-equity ratio of 0.11, a current ratio of 0.85 and a quick ratio of 0.83. The firm’s 50 day simple moving average is $450.37 and its two-hundred day simple moving average is $430.90. Chemed Corporation has a 1-year low of $365.20 and a 1-year high of $511.85.
Chemed (NYSE:CHE – Get Free Report) last issued its quarterly earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.30 by $0.35. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The business had revenue of $657.51 million during the quarter, compared to analyst estimates of $659.22 million. During the same quarter in the prior year, the business posted $5.63 EPS. Chemed’s revenue for the quarter was up 1.6% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. Research analysts expect that Chemed Corporation will post 22.67 EPS for the current fiscal year.
Chemed Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th were issued a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a dividend yield of 0.5%. The ex-dividend date of this dividend was Thursday, May 28th. Chemed’s dividend payout ratio is 13.08%.
Chemed Profile
Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.
The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.
Featured Stories
- Five stocks we like better than Chemed
- Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to Benefit
- Shopify’s Quiet AI Strategy Could Be Its Biggest Advantage Yet
- Why These 3 Nuclear ETFs Are Getting a Fresh Look as AI Power Demand Rises
- 3 Aerospace Suppliers That Could Benefit as Aircraft Makers Face Bottlenecks
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE – Free Report).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.
